Newsletter
New biopharma technologies keep coming. The hard part is deciding what's worth doing, how to do it, and how to actually bring it to the market.
Subscribe to the Chivanta newsletter for practical perspectives on biopharma BD, product market assessment, CDMO operations and cost, and commercializing new technologies.
Free · Unsubscribe anytime
The format varies: an analysis, lessons from experience, a framework, or an industry observation.
Partnering, licensing, careers, and cross-cultural communication.
Market selection, commercial feasibility, and resource trade-offs.
Clients, quotes, cost, GMP, and delivery.
How cell therapy and other new technologies reach the market.
Clients often assume that if the lab can make it, the plant can produce it next month. But between R&D and GMP sit the process, the documentation, and the quality system.
How BD picks the first overseas market.
When market thinking should step in, and when it should step back.
When there's something worth sharing, I'll write an article email to you. It's usually 1~2 weeks an email.
The newsletter pulls out the key points of new articles and shares observations and experiences that haven't become articles yet.
It's free. Every email has an unsubscribe link at the bottom.
CHIVANTA NEWSLETTER
Subscribe to the Chivanta newsletter for practical perspectives on biopharma BD, product market assessment, CDMO operations and cost, and commercializing new technologies.
Free · Unsubscribe anytime